On Friday, a Food and Drug Administration (FDA) advisory committee rejected a plan to administer booster shots of Pfizer’s COVID-19 vaccine to the public. The FDA says it needs more data before approving what would be the third shot.
The FDA says the count was not close, with a 16-2 ratio against the plan. However, the panel could still recommend the shots for older populations. The FDA says scientists continued debating the need for older individuals after the initial vote.
UPDATE: The FDA panel has now approved Pfizer-BioNTech COVID-19 booster shots only for people 65 and older or at high risk.
“It’s likely beneficial, in my opinion, for the elderly, and may eventually be indicated for the general population. I just don’t think we’re there yet in terms of the data,” says Dr. Ofer Levy, a vaccine and infectious disease specialist at Boston Children’s Hospital.
If the third dose of Pfizer’s vaccine is the best route for individuals vulnerable to COVID — who also want a booster — the sooner it is safe, tested, and available, the better. We, of course, root for that. As for President Joe Biden, he continues to add up his losses.
A week ago, Biden promised that all American adults would have access to the booster by Sept. 20. That’s isn’t happening, making Biden look even worse. Like I explained, we don’t ask game-managing QBs to win. Instead, we ask them not to lose. Between the FDA refusal and the failed drone strike in Afghanistan, Biden is still losing today.